Long-term engraftment and phenotype correction has been difficult to achieve in humans after in utero stem cell transplantation mainly because of allogeneic rejection. Autologous cells could be obtained during gestation from the amniotic fluid with minimal risk for the fetus and the mother. Using a sheep model, we explored the possibility of using amniotic fluid mesenchymal stem cells (AFMSCs) for autologous in utero stem cell/gene therapy. We collected amniotic fluid (AF) under ultrasound-guided amniocentesis in early gestation pregnant sheep (n = 9, 58 days of gestation, term = 145 days). AFMSCs were isolated and expanded in all sampled fetal sheep. Those cells were transduced using an HIV vector encoding enhanced green fluorescent protein (GFP) with 63.2% (range 38.3-96.2%) transduction efficiency rate. After expansion, transduced AFMSCs were injected into the peritoneal cavity of each donor fetal sheep at 76 days under ultrasound guidance. One ewe miscarried twin fetuses after amniocentesis. Intraperitoneal injection was successful in the remaining 7 fetal sheep giving a 78% survival for the full procedure. Tissues were sampled at postmortem examination 2 weeks later. PCR analysis detected GFP-positive cells in fetal tissues including liver, heart, placenta, membrane, umbilical cord, adrenal gland, and muscle. GFP protein was detected in these tissues by Western blotting and further confirmed by cytofluorimetric and immunofluorescence analyses. This is the first demonstration of autologous stem cell transplantation in the fetus using AFMSCs. Autologous cells derived from AF showed widespread organ migration and could offer an alternative way to ameliorate prenatal congenital disease.
INTRODUCTION
treat congenital disorders in the fetus using cells capable of self-renewal that can enhance or substitute the affected tissues/organs of the fetus. The small fetal size Many congenital diseases have a relatively low prevalence, but collectively they represent a large burden of provides a stoichiometric advantage, allowing the transplantation of much larger cell doses on a per kilogram disease (28). It is estimated that they are responsible for over a third of all pediatric hospital admissions, and for basis than can be achieved after birth (4, 7) . Prenatal treatment could also avoid complications occurring in up to 50% of the total cost of pediatric hospital treatment (28). Due to the improvement in medical care, afthe postnatal period, as some genetic diseases damage the organ in utero and lead to irreversible changes (10) . fected patients can now survive to adulthood, requiring continued therapy.
Finally, the immunological naivety in the early gestation fetus has given rise to the concept of fetal tolerance, In utero stem cell transplantation (IUSCT) aims to 1016 SHAW ET AL. the inability to raise an immunological response against
MATERIALS AND METHODS foreign antigens (21). However, it is now clear that the
Animal Procedures human fetus may have a functionally developed immune Nine fetuses from seven ewes (Romney breed) were system as early as the second trimester of gestation (49) used in these experiments. The experimental design is and allogeneic cells injected at that time engraft poorly illustrated in Figure 1A . Ewes were time mated after (30, 35) . In humans, successful IUSCT using allogeneic receiving intravaginal progesterone suppositories for 2 hematopoietic stem cells (HSCs) has been limited to feweeks to induce ovulation. General anesthesia was intuses with severe immunologic defects, where the effecduced with ketamine (4 mg/kg, Merial, UK) intravetive lack of immune response to allogeneic cells mean nously and, after intubation, the ewes were maintained that transplanted genetically normal cells have a prolifon isoflurane-Vet 3% (Merial, UK) in oxygen. Fetal erative advantage (46) . measurements were confirmed by ultrasound as preMesenchymal stem cells (MSCs) appear to be less viously described (11) . The first procedure, amniocenteimmunogenic than their hematopoietic counterparts (2, sis (Fig. 1B) , was performed in early pregnancy (57-61 34). IUSCT of first trimester human fetal blood MSCs days of gestation, term = 145 days) under ultrasound in mice with osteogenesis imperfecta (OI) was reported guidance using a 22-gauge, 15-cm echo-tip needle to ameliorate skeletal pathology (23). In a human fetus (Cook Medical, USA) and 10 ml of amniotic fluid was affected by OI successful engraftment of allogeneic withdrawn from each amniotic sac. After recovery fetal MSCs with 5% chimerism was obtained at 8 months of well-being was confirmed using ultrasound examination. age (27) . In normal fetal sheep, where the immune sysApproximately 2 weeks later (71-83 days of gestatem is believed to develop from 65 to 70 days of gestation) sheep were reanesthetized as above for the second tion (29) , transplantation of allogeneic fetal liver cells procedure. Transduced AFMSCs (1-2 ml) were injected resulted in levels of mixed chimerism as high as 30% under ultrasound guidance into the peritoneal cavity of after a single intrauterine dose (19,54,55) and low-level the fetus from which they were derived (Fig. 1C ) using engraftment lasted for over 2 years. Increasing the numa 20-gauge 15-cm echo-tip disposable needle (Cook bers of T-cells added back to the transplant increased Medical). To ensure correct needle placement within the the level of chimerism, although the corresponding inperitoneal cavity, the needle was inserted through the creased risk of graft-versus-host disease limits the numanterior abdominal wall of the fetal sheep superior and ber of allogeneic cells that can be transplanted (6, 8) . Atlateral to the fetal bladder to avoid the umbilical arteries, tempts to treat other diseases such as sickle cell or and microbubbles were observed moving within the metabolic storage disorders have been unsuccessful, peritoneal cavity as the vector was instilled. Fetal welleven where a suitably matched donor has been available being was examined after the procedure. A scheduled (14,51).
postmortem examination was performed approximately Autologous cells could potentially overcome these 3 weeks after intraperitoneal AFMSC transplantation obstacles (1, 35, 38, 43, 53) . Multi-and pluripotent stem (89-103 days of gestation). There was widespread samcells can be easily derived from amniotic fluid (5, 15) pling of maternal and fetal tissues that were fixed in 4% and their ability to differentiate into various lineages paraformaldehyde (pH 7.4) overnight and processed into such as myogenic, adipogenic, osteogenic, neuronal, enwax for immunohistochemistry analysis. In parallel, tisdothelial, and hepatic cells has been extensively investisues were also snap-frozen for protein extraction and gated (15, 16, (24) (25) (26) 48 ). Moreover, we and others have PCR analysis. Cord blood, spleen, liver, and bone mardemonstrated that amniotic fluid-derived stem cells can row of fetal sheep and maternal peripheral blood and be easily transduced without losing their potential (16, bone marrow were collected for FACS flow cytometry. 22). Therefore, transplantation of genetically corrected All procedures on animals were conducted in accorautologous amniotic fluid stem cells into a fetus could dance with UK Home Office regulations and Guidance represent an alternative therapeutic strategy for the treatfor the Operation of Animals (Scientific Procedures) Act ment of severe congenital diseases.
(1986). In this study, we investigated the feasibility and potential for amniotic fluid mesenchymal stem cells Ex Vivo Expansion of Amniotic Fluid Mesenchymal (AFMSCs) in order to combine IUSCT and gene therapy Stem Cells into one therapeutic strategy. With this aim we used the fetal sheep, which has the advantages of long gestational Amniotic fluid samples collected from fetal sheep were centrifuged (300 × g) for 5 min. Pellets were resusage, similar fetal size, and comparable fetal development and physiology to human pregnancy (10, 13) and in pended in the amniotic culture medium (ACM), which consisted of αMEM (63%, Life Technology, Gaitherswhich there is wide experience with fetal interventional procedures (9,12).
burg, MD), Chang medium (20%, Chang B plus Chang C; Irvine Scientific, Santa Ana, CA), fetal bovine serum changing new medium and the adherent cells were cultured until preconfluence. Adherent cells were detached (FBS, 15%, Invitrogen, UK), and streptomycin, penicillin, and L-glutamine (1% each, Invitrogen). Cell seeding from the plastic substrate using 0.05% trypsin and 0.02% sodium-EDTA (Life Tech). Cells were passaged was performed on single 35-mm Falcon petri dishes (Becton Dickinson, Los Angeles, CA) that incubated at into 100-mm petri dishes and further split one to four once the dish reached 70% confluence. Cell size and 37°C with 95% air and 5% carbon dioxide. After 3 days, nonadherent cells and debris were discharged while number was determined using a hemocytometer (Ma-rienfeld, Germany) before and after viral transduction. phatase kit was used for osteogenic cells staining according to the manufacturer's instruction (SigmaThe formula used for the doubling time (hours) was h*log(2)/log(c2/c1), where c1 is initial seeding cell Aldrich). ACM was used as a control growth medium in control conditions. number, c2 is cell number after growth, and h is hours of culture.
Lentiviral Vectors Preparation and Transduction of Sheep Amniotic Fluid Stem Cells Cell Cycle Analysis
A lentivirus vector encoding the the HIV-1 central Propidium iodine (PI) was used to stain cell nucleic polypurine tract element, the Spleen Focus Forming Viacid to identify the proportion of cells that are in one of rus LTR promoter, and the marker gene eGFP was used. the three interphase stages of the cell cycle. Briefly, 1 × Vector stocks were generated as previously described 10 6 AFMSCs were washed in PBS and centrifuged to (17, 39) , and were concentrated by ultracentrifugation at produce a cell pellet. Seventy percent ethanol (1 ml) was 23,000 × g for 2 h at 4°C using a Beckmann ultracentriadded to fix the cell pellet during centrifugation. After fuge. The virus particles were resuspended in X-Vivo 10 30-min incubation on ice, cells were pelleted using a and stored at −80°C. The number of infectious particles high-speed centrifuge at 3000 rpm for 5 min. Ribowas estimated by flow cytometry of 293T cells, 72 h nuclease A solution (50 µl, 100 µg/ml) and PI solution after exposure to serial dilutions of virus stock. Cells (400 µl, 50 µg/ml) were added directly into the PBS cultured in ACM (1 × 10 6 ) and were seeded into 24-well washed pellet for 10 min at room temperature. The samnon-tissue culture dishes. After 24 h they were transples were analyzed by flow cytometry as described duced with the lentivirus vector at a multiplicity of inbelow.
fection of 10 virus particles per cell. Cells were incubated with the vector for 48 h at 37°C in 95% air and Differentiation and Characterization of Amniotic Fluid 5% carbon dioxide. Transduced cells were treated with Mesenchymal Stem Cells trypsin and replated into 100-mm dishes for further In order to characterize the isolated, cultured, and growth in ACM. transduced amniotic fluid cells, the following surface markers were used. Mouse anti-sheep CD14, CD31, Flow Cytometry Analysis CD44, CD45, and CD58 antibodies conjugated with fluSingle cell suspensions of fetal spleen, liver, and orescein isothiocyanate (FITC) (AbD Serotec, UK), and bone marrow were prepared immediately after animal mouse anti-human CD166 conjugated with phycoerysacrifice by straining fetal tissue through a 40-µm nylon thrin (PE) (BD Pharmingen, UK) were used for characmesh cell strainer (BD, UK). The fetal tissue was passed terization of the nontransduced AFMSCs. Goat anti-mouse through the cell strainer with PBS rinsing. After washing Alexa Fluor 568 (Invitrogen) was used as secondary with PBS, red blood cell lysis buffer was added to the antibody to mouse CD14, CD31, CD44, CD45, and cell pellet for 5 min at 37°C, which was then resus-CD58 in order to identify the GFP-transduced AFMSC pended in PBS for flow cytometry analysis. Mononucells. Antibodies (10 µl) were stained with 5 × 10 5 cells clear cells were isolated from umbilical cord and materin 100 µl ice-cold PBS. The incubation time was 15 min.
nal blood samples by density gradient centrifugation The stained cells were analyzed with flow cytometry.
using Ficoll-Paque solution (Stem Cell Technology, To induce adipogenic differentiation, cells from pasCanada). Diluted blood solution (10 ml of blood and 25 sage 2 were seeded at a density of 3,000 cells/cm 2 and ml of buffer) was centrifuged with Ficoll solution (15 were cultured for 21 days in DMEM low-glucose meml) 30 min at 2000 rpm at room temperature without dium with 10% FBS, antibiotics (Pen/Strep, Gibco/ breaking to form the interphase. Then the interphase was BRL), and adipogenic supplements [1 mM dexamethacarefully transferred to another new tube for further sone, 1 mM 3-isobutyl-1-methylxanthine, 10 mg/ml inanalysis. Single cell suspensions from control untranssulin, 60 mM indomethacin (Sigma-Aldrich, UK)]. The fected ewes and their fetuses were used as negative concells were stained with Oil red O (Sigma-Aldrich). ACM trols. The cells were acquired by Becton Dickinson was used as a control growth medium in control condiFACSCalibur and LSR II machines (Becton Dickinson, tions.
San Jose, CA) and analyzed using FlowJo version 5.7.1 For osteogenic differentiation, cells from passage 2 software (Tree Star). Ten thousand events were colwere seeded at a density of 3,000 cells/cm 2 and were lected per sample and the data were stored as list mode cultured for 21 days in DMEM low-glucose medium files. with 10% FBS (Gibco/BRL), Pen/Strep, and osteogenic PCR Analysis supplements [100 nM dexamethasone, 10 mM betaglycerophosphate (Sigma-Aldrich), 0.05 mM ascorbic acid-DNA was extracted from fetal and maternal tissues using a minikit (Invitrogen, USA) and the quality was 2-phosphate (Wako Chemicals, UK)]. An alkaline phos-confirmed using a nanodrop machine (NanoDrop Techprimary antibodes were applied. Secondary goat antirabbit (Alexa Fluor 594) and goat anti-mouse (Alexa nologies, USA). Sample DNA (4 µg) was used for the first PCR reaction (30 cycles of 45 s at 65°C). The folFluor 488) antibodies were used. The conditions for primary and secondary antibody staining were the same as lowing primers were used for first round amplification of eGFP: forward, 5′-TGAACCGCATCGAGCTGAA for hepatocyte analysis. The stained tissues were covered by VECTASHIELD HardSet Mounting Medium GGG-3′ and reverse, 5′-TCCAGCAGGACCATGTGA TCGC-3′. A second nested PCR round was performed with DAPI for nuclear staining (Vector Laboratories, USA). The slides were observed under inverted immu-(25 cycles of 45 s at 60°C) using the following second round primers: forward, 5′-GGCACAAGCTGGAGTA nofluorescence microscopy (Leica, Germany). In order to quantify the number of AFMSCs migrated in the fetal CAACT-3′ and reverse, 5′-CCATGTGATCGCGCTT CT-3′. PCR products were analyzed on 1.2% agarose liver, we counted GFP and CK18 positive/negative stained cells in four high-power fields per fetal liver. gel stained with ethidium bromide. DNA from transduced amniotic fluid cells was used as a positive control.
Values (mean ± SD) were expressed as the percentage of single-or double-positive stained cells per total nuclei Western Blot Analysis in each high power field. Cell pellets and homogenized tissues were resuspended in 200 µl PBS and 200 µl 2× protein sample RESULTS buffer [0.5 M Tris-HCl (pH 6.8), 5% glycerol, 2% soUltrasound Guided Amniocentesis and Intraperitoneal dium dodecyl sulfate, and 100 mM dithiothreitol]. SamInjection of AFMSCs ples were boiled for 5 min and centrifuged at 16,000 × Amniotic fluid was successfully sampled in all nine g for 15 min to remove insoluble material. Samples were fetuses. One ewe subsequently miscarried twin fetal loaded onto a precast 7.5% Ready gel with a 4.5%
sheep a few days after the amniocentesis procedures, but stacker (BioRad Laboratories, Hercules, CA) and run for before intraperitoneal injection could be performed. In-1 h at 200 V. After electrophoresis, proteins were transtraperitoneal injection (n = 7) was successfully perferred to nitrocellulose membranes in a Bio-Rad Elecformed with no fetal or maternal mortality until planned troblotter Apparatus. Membranes were blocked in TBST postmortem examination in the remaining seven fetal (TBS, 0.05% Tween 20, Sigma, UK) containing 5%
sheep, giving a 78% survival for the full procedure. Exmilk for 1 h at room temperature and then reacted overperimental details are listed in Table 1 . There was no night at 4°C with rabbit anti-GFP (Invitrogen, USA) dimaternal morbidity including fever, abdominal distenluted 1:2000 in TBST-milk. After three washes in TBST, sion, hemorrhage, or ruptured amniotic membranes. the membranes were treated with affinity-purified horseThere was no evidence of fetal hemorrhage or trauma radish peroxidase-conjugated goat anti-rabbit IgG (Prorelative to the injection procedure. mega, Madison, WI, USA) diluted 1:4000. Membranes were washed three times in TBST, and then developed Sheep AFMSC Isolation, Expansion, and Characterization with a 3,3′-diaminobenzidine-based horseradish peroxidase detection kit (Vector Laboratories, USA).
AFMSCs could be isolated and expanded in vitro from all the nine sheep (100%). The initial numbers of Immunofluorescence viable cells from 10 ml amniotic fluid in all animals were less than 20,000 cells, but they were easy to exFresh fetal tissues were embedded in OCT, snap frozen in methyl-butane and liquid nitrogen, and cut into pand in petri dishes without feeder layer and demonstrated a doubling time ranging from 36 to 48 h ( Fig.  10-15 -µm sections using a cryostat (OTF, Bright, UK). Blocking solution was prepared with 1% BSA, 0.15% 2A). AFMSC growth velocity and differentiation potential was maintained for up to 10 passages ( Fig. 2A) . In glycine, and 0.1% Triton in PBS and preserved at 4°C. To co-stain hepatocytes expressing GFP, mouse antiorder to achieve a sufficient number of cells for transplantation, cells were cultured for up to 20 passages. sheep CK18 (Abcam, UK), mouse anti-sheep α-fetoprotein antibody-2 (AFP) (Thermo Scientific, UK), and
The number of injected cells was correlated with the time available for their culture from amniocentesis to rabbit anti-GFP polyclonal (Invitrogen, USA) primary antibodies were applied at 1:150 concentration in blocktransplantation (time of cell culture and transduction in days in Table 1 ). Subconfluent cells also showed no eviing solution overnight at 4°C. Goat anti-rabbit (Alexa Fluor 488, Invitrogen, USA) and goat anti-mouse (Alexa dence of spontaneous differentiation (data not shown).
The cell size and DNA content from cell cycle analysis Fluor 568) secondary antibodies were incubated for 2 h at room temperature with blocking solution at 1:150 did not show a significant difference between pre-and posttransduction AFMSCs (Fig. 2B, C) . Samples of concentration. To co-stain myocytes expressing GFP, rabbit anti-laminin (Abcam, UK) and mouse anti-GFP AFMSCs and GFP-AFMSCs had higher ratio in G 0 /G 1 Fig. 5C) ]. Maternal liver, (Fig. 2C) .
The surface markers of mesenchymal stem cells, antibone marrow, kidney, lung, heart, and adrenal gland were examined using GFP nested PCR but were negasheep CD44, CD58, and CD166, were strongly positive in cultured sheep AF cells. The monocyte and lymphotive, indicating no evidence of maternal engraftment after fetal transplantation (Fig. 5D ). cyte markers, anti-sheep CD14, CD31, and CD45, showed negative in sheep cells (Fig. 2D) . The results are the Analysis of GFP Protein Expression in Fetal Organs same either in the pre-or posttransduced AFMSCs. The two groups of cells that could be expanded in vitro Cytofluorimetric analysis showed low-level presence of transduced AFMSCs in fetal bone marrow (0.85 ± showed the ability to differentiate into adipogenic and osteogenic lineages following the differentiation proto-0.13%) and liver (1.24 ± 0.08%). Figure 6 shows one of the animals with positive stainin in bone marrow and cols (Fig. 3) .
liver. There were no GFP-positive cells in fetal umbiliAFMSCs Transduction With Lentivirus GFP Vector cal cord blood and spleen, or maternal blood and bone marrow. GFP protein expression was also assessed by Transduction efficiency, assessed 3 days after lentiviral transduction using cytofluorimetric analysis, was on Western blot in those fetal tissues in which GFP DNA was detected (Table 2 ). There was insufficient protein average 63.2% (range 38.3-96.2%) (Fig. 4A, B , Table  1 ). GFP expression was also detected when AFMSCs available in samples of fetal gonad and peritoneum for Western blot analysis. The most frequent tissues to have were observed under fluorescence microscopy (Fig. 4C) . Cell kinetics of GFP transduced AFMSCs was similar positive GFP protein expression were the placenta (6/7, 86%), the fetal liver, and the amniotic membranes (5/7 to nontransduced AFMSCs ( Fig. 2A) . fetuses, 71%, Table 2 ). Of all tissue samples that were
Detection of GFP DNA in Fetal and Maternal Organs
PCR positive for GFP, Western blot confirmed GFP protein in 77.8% (21/27) of them. The presence of GFP GFP DNA was detected in many fetal organs using nested PCR, suggesting systemic spread of GFP-positive protein detected 3 weeks after injection of transduced AFMSCs was strong evidence of cell migration in these cells after fetal injection ( Table 2 ). The amniotic membrane and placentomes were most frequently positive tissues after transplantation. Finally, to confirm the presence of GFP-positive (85.7%), followed by the fetal liver, which was positive in five fetuses (71.4%). GFP DNA was also detected in AFMSCs in fetal tissue, we used immunofluorescence to analyze selective organs including fetal liver, skeletal fetal muscle, umbilical cord, heart, adrenal gland, gonad, bone marrow, and peritoneum. The cell number we inand cardiac muscle, and placenta. For hepatocyte differentiation, we analyzed expression of GFP, cytokeratin jected in each animal was varied. The length of cell culturing and final cell number for injection showed moder-18 (CK18), and AFP in the liver of the four fetuses that had GFP-positive staining. Two liver lobes were examate correlation (r = 0.59) (Fig. 5A ). There was no significant correlation between the number of injected ined in each fetus. In some sections, GFP-positive cells did not co-stain with CK18 ( Fig. 7A-D) . Only a few cells and the presence of GFP-positive cells in the differ- GFP-positive cells presented in animals were seen coAFMSCs in the liver after autologous transplantation (Fig. 8B) . stained with CK18-positive cells in both liver lobes, suggestive of hepatocyte differentiation (Fig. 7E-G ). More-DISCUSSION over, the percentages of positive cells per slide were 2.97 ± 1.15% for GFP + /CK18 − cells and 1.08 ± 0.33% This is the first study to describe in utero autologous transplantation and migration of AFMSCs. We showed for GFP + /CK18 + cells in the fetal liver (Fig. 7H) . For muscle differentiation, we analyzed the expression of that using this system, it is possible to obtain a widespread migration of transduced autologous cells, with GFP and laminin. GFP-positive cells were clearly detected in the skeletal muscle (Fig. 7I) and heart (Fig. 7J) evidence of expression of transgenic protein in major fetal organs, bone marrow, and blood. Tissue analysis of four fetuses. No myogenic differentiation could be observed when muscles were co-stained with laminin.
by PCR, Western blot, immunofluorescence, and cytofluorimetric assay revealed that AFMSCs injected into Abundant GFP-positive cells could be detected in placentome (Fig. 7K-M) .
the peritoneal cavity preferentially localized in fetal liver, muscle, and heart. Moreover, a small number of Both AFMSCs and GFP-AFMSCs did not show CK18 expression from our study, while the noninjected cells expressing transgenic protein in the liver co-stained with markers of hepatocyte differentiation. fetal sheep as a positive control showed strong expression of CK18 in the liver (Fig. 8A) . AFP, another liverUsing ultrasound-guided amniocentesis, a common clinical procedure with a known fetal loss rate of apspecific marker, also demonstrated the presence of GFP- 
animal (total = 18) 7 (39%) 4 (22%) 6 (33%) 6 (33%) 7 (39%) 3 (17%) 5 (28%) Western blot analysis of GFP protein Liver
proximately 1% (45), we were able to isolate AFMSCs ilar to that we have previously reported for both intraamniotic and intraperitoneal gene transfer to fetal sheep in 100% of the animals. A miscarriage occurred in one ewe carrying twin pregnancies despite a straightforward (9) . In comparison, another study of xenotransplantation of human cord blood and fetal bone marrow MSCs into ultrasound-guided amniocentesis procedure. This compares favorably to the higher rates of fetal loss observed fetal sheep had an overall 37.5% fetal loss rate (33) . In our experimental setting, mesenchymal progeniin other studies where different sources of autologous MSCs were used for autologous in utero transplantation.
tors were derived in 100% of the animals. In keeping with previous studies in sheep (20) and other species In particular, fetal transplantation of autologous MSCs derived from fetal liver in sheep carried an overall mor-(16), the AFMSCs were maintained in feeder-free cultures, had a doubling time of approximately 36-48 hours, tality rate of 73% (42). For IUSCT in fetal sheep, transuterine ultrasound-guided injection has been shown to and displayed mesenchymal stem cell markers (CD44, CD58, and CD166), while being negative for macroachieve a higher rate of engraftment when compared to an open delivery procedure at hysterotomy (70% vs.
phages, hematopoietic, and endothelial markers (CD14, CD31, and CD45). When cultured in conditional me-20%) (32) , despite in both cases cells were delivered intraperitoneally, commonly the route of delivery for fedium (48) these cells could differentiate into adipogenic and osteogenic lineages. The potential of differentiation tal blood transfusion in clinical practice although less commonly performed than cordocentesis (47). In our and characterization of all the surface markers did not change even after viral transduction. After being transstudy, we did not observe any miscarriage related to the transplantation procedure. Our miscarriage rate was simduced, expanded undifferentiated cells were autotrans-planted without sorting for two reasons. Firstly, we were served was admittedly low. However, for some congenital diseases, such as severe hemophilia, only 1% levels pleased by the relatively high level of gene transfer that was achieved in the AFMSCs. Secondly we wished to of protein expression are required to ameliorate the severe phenotype (50) . Thus, for many congenital diseases avoid clonal selection of the cells and to observe what could happen with minimal manipulation. While we this may be sufficient to improve the phenotype or even effect a cure (37) . have previously shown that AFS cells can be efficiently transduced using adenoviral vectors (22), lentivirus vec-
The number of expanded transduced amniotic fluid cells increased as the length of time available for cell tors have the advantage of allowing sustained transgene expression (36) . We have shown that lentivirus vectors culture increased (Fig. 5A) . Interestingly, however, there was no evidence of a dose-response effect, since the are able to efficiently transduce sheep AFMSCs. This is particularly relevant when considering that various pronumber of injected cells did not correlate with the number of organs containing transduced cells (Fig. 5B, C) . genitors could be isolated from the amniotic fluid, and have demonstrated the possibility to differentiate into Moreover, in some of the cases, the number of organs in which the GFP protein was detected was higher than myocardium, lung epithelial cell, smooth muscle, and neuron cells (3, 15, 24) . More recently we have also rethe number of organs in which GFP DNA was detected.
It is likely that cells were generating a chimerism and ported that ckit + /LIN − selected AF cells have hematopoietic potential both in vitro and in vivo (18). As a consewere not present in the entire organ. Since different samples of the same organs were analyzed for DNA and quence, autologous AF cells could be engineered and used to engraft a fetus affected by a congenital disorder protein, it is possible that some samples did not contain positive cells. Injected cells appeared to migrate mainly in order to provide for expression of the damaged/defective gene.
to the liver, heart, adrenal gland, and umbilical cord of the fetus, and to extraembryonic tissues such as the amThe level of injected cells in fetal tissues that we ob- niotic membranes, placentomes, and amniotic fluid.
of autologous MSCs achieved was not significantly different from that observed after allogeneic-derived MSCs Cells delivered to the peritoneal cavity are likely to migrate into the blood stream, from where they can travel (0.16% vs. 0.56%). However, engraftment in the fetal liver was higher (0.65% vs. 0.23%) after autologous transto the placenta and membranes via the umbilical vein in the cord. This study was performed in normal fetuses in plantation (42). Similarly, we observed a good number of injected cells in the fetal liver, confirmed also by the which there is no engraftment advantage for the injected cells. Different results may be obtained in animal modappearance of rare cells coexpressing GFP and CK18 or AFP. Further studies need to be conducted to evaluate the els of disease where damaged organs may provide a niche for injected cells to engraft.
possibility that AFMSCs may engraft in the liver. This could be particularly relevant since hepatocyte differentiaThe question of whether autologous IUSCT is superior to allogeneic cells is as yet unresolved. In a previous tion may lead to the treatment of congenital metabolic disorders (31, 40) . Our results could be improved by prestudy in sheep of fetal transplantation of MSC derived from fetal liver, the level of bone marrow engraftment conditioning the cells in hepatocyte differentiation media FACING PAGE Figure 7 . Immunofluorescence for GFP expression and markers of MSC differentiation. GFP-positive AFMSC migration and differentiation was studied using GFP immunofluorescence and co-staining with tissue markers in fetal organs such as the liver (CK18; A-G) and skeletal muscle and heart (laminin; H-I). In fetal liver, GFP-positive cells (green) mainly localized in the stroma (A-D) and did not co-stain with CK18, a marker of hepatocytes stained red. In another section, however, a few rare cells costained for GFP and CK-18 (E-G, indicated by the arrowhead). Some cells that only stained for GFP remained in the stroma (41,52) and by injection in the umbilical vein (44). The markers does not fully address the ability of these cells to generate functional hepatocytes. latter in particular might preferentially target the liver when compared with the widespread tissue migration obIn summary, this study demonstrates widespread and systemic migration after fetal injection of transduced auserved after peritoneal injection in this study.
In addition, the interval between injection and schedtologous AFMSCs in the sheep. We successfully cultured sheep AFMSCs, and achieved a high level of uled postmortem was relatively short. We cannot exclude that differentiation may occur mainly (or only) by lentivirus vector-mediated gene transfer. Longer term follow-up studies are needed to investigate whether cell cell fusion and further studies are needed, possibly in a small animal model, to further investigate this aspect. engraftment is occurring. Our results, however, demonstrate that this approach may hold promise for targeted Moreover, the cytoplasmic marker (i.e., GFP) in an autologous model does not distinguish cell fusion from diftreatment of severe early onset genetic diseases that can be diagnosed in utero. ferentiation. Finally, even the expression of hepatocyte 
